v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash Flows From Operating Activities    
Net income $ 3,942,000 $ 7,734,000
Adjustments to reconcile net income to net cash used in operating activities:    
Deferred income tax expense 498,000 832,000
Depreciation and amortization 1,044,000 591,000
Share-based compensation [1] 989,000 184,000
Interest related to contract termination liability payment 109,000 31,000
Changes in    
Securities segregated for regulatory purposes 23,921,000 28,961,000
Receivables from customers 4,509,000 (2,052,000)
Receivables from non-customers (804,000) (214,000)
Receivables from and deposits with broker-dealers and clearing organizations (4,330,000) (4,251,000)
Securities borrowed (99,681,000) 140,928,000
Securities owned, at fair value 1,910,000 1,270,000
Prepaid expenses and other assets (2,185,000) (1,666,000)
Payables to customers (9,259,000) (55,904,000)
Payables to non-customers (3,071,000) (527,000)
Drafts payable (152,000) (199,000)
Payables to broker-dealers and clearing organizations 735,000 4,534,000
Accounts payable and accrued liabilities (245,000) 464,000
Securities loaned 50,712,000 (146,918,000)
Securities sold, not yet purchased, at fair value (19,000)
Net lease liabilities (25,000) (2,000)
Taxes payable (1,020,000) (732,000)
NFS business development credits (425,000) (425,000)
Other deferred revenue 20,000
Contract termination liability payment (1,003,000) (1,000,000)
Net cash used in operating activities (33,830,000) (28,361,000)
Cash Flows From Investing Activities    
Purchase of office facilities and equipment (124,000) (68,000)
Purchase of software (1,578,000) (1,667,000)
Additions to property, office facilities, and equipment (243,000) (1,082,000)
Acquisition of BMLG assets (441,000)
Investment in FusionIQ (2,000,000)
Transaction with J2 Financial (35,000)
Net cash used in investing activities (4,386,000) (2,852,000)
Cash Flows From Financing Activities    
RISE cash distribution (35,000)
Repayments of long-term debt (44,000) (43,000)
Net cash (used in) / provided by financing activities (79,000) (43,000)
Net change in cash and cash equivalents, and cash segregated for regulatory purposes (38,295,000) (31,256,000)
Cash and cash equivalents, and cash segregated for regulatory purposes - beginning of period 168,458,000 164,537,000
Cash and cash equivalents, and cash segregated for regulatory purposes - end of period 130,163,000 133,281,000
Reconciliation of cash, cash equivalents, and cash segregated for regulatory purposes    
Cash and cash equivalents - end of period 28,949,000 5,200,000
Cash segregated for regulatory purposes - end of period 101,214,000 128,081,000
Cash and cash equivalents, and cash segregated for regulatory purposes - end of period 130,163,000 133,281,000
Supplemental cash flow information    
Cash paid during the period for income taxes 1,243,000 3,137,000
Cash paid during the period for interest 78,000 80,000
Non-cash investing and financing activities    
Transaction with J2 Financial [2] 350,000
Share-based compensation $ 201,000
[1] Refer to Note 20 – Employee Benefit Plans for further detail.
[2] Refer to Note 10 – Software, Net in the Company’s 2024 10-K for further information.